Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 21:37 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- DKK 33.8T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | DKK 34B | DKK 96.87 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | DKK 63.2B | DKK 665.05 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | DKK 45.1B | DKK 664.64 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | DKK 35.8B | DKK 847.34 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | DKK 27.5B | DKK 200.82 | 1.24% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | DKK 50.1B | DKK 637.16 | 1.59% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | DKK 66.8B | DKK 441.96 | 1.88% down | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | DKK 32.5B | DKK 577.86 | 1.01% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | DKK 155.3B | DKK 135.42 | 1.97% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | DKK 192.3B | DKK 265.39 | 0.59% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | DKK 50.8B | DKK 145.71 | 2.24% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | DKK 59.2B | DKK 2,117.84 | 1.87% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | DKK 30.7B | DKK 280.45 | 0.48% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | DKK 265.2B | DKK 461.31 | 1.38% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | DKK 306.3B | DKK 262.53 | 8.74% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | DKK 215.7B | DKK 349.80 | 0.75% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | DKK 52.9B | DKK 314.58 | 1.43% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | DKK 466B | DKK 145.84 | 0.66% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | DKK 55.1B | DKK 844.82 | 2.47% down | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | DKK 39.1B | DKK 1,954.63 | 3.94% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | DKK 2.23T | DKK 904.70 | 3.61% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | DKK 31.6B | DKK 329.02 | 3.86% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | DKK 41.8B | DKK 1,028.75 | 3.33% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | DKK 103.4B | DKK 1,610.69 | 4.57% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | DKK 4.38T | DKK 1,819.75 | 2.04% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | DKK 42.5B | DKK 650.61 | 3.27% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | DKK 8.2T | DKK 9,203.80 | 2.29% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | DKK 812.3B | DKK 397.41 | 2.05% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | DKK 114.4B | DKK 1,743.59 | 5.32% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | DKK 650.7B | DKK 6,289.77 | 2.35% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | DKK 899.2B | DKK 3,546.73 | 2.94% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | DKK 89.5B | DKK 179.09 | 1.54% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | DKK 1.95T | DKK 1,030.11 | 2.57% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | DKK 3.41T | DKK 1,931.47 | 0.86% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | DKK 162.2B | DKK 3,808.58 | 3.16% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | DKK 103.7B | DKK 532.56 | 0.22% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | DKK 55.2B | DKK 795.64 | 1.88% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | DKK 81B | DKK 418.39 | 0.02% down | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | DKK 311B | DKK 2,722.75 | 0.97% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | DKK 1.07T | DKK 187.60 | 1.85% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | DKK 42B | DKK 297.34 | 1.25% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | DKK 84.2B | DKK 101.02 | 1.00% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | DKK 653B | DKK 325.75 | 1.56% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | DKK 1.85T | DKK 1,194.89 | 1.87% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | DKK 38B | DKK 55.86 | 3.19% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | DKK 753.4B | DKK 313.76 | 2.25% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | DKK 48.6B | DKK 924.25 | 1.25% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | DKK 48.4B | DKK 442.64 | 4.15% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | DKK 1.23T | DKK 707.56 | 0.58% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | DKK 1.17T | DKK 264.78 | 1.42% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | DKK 48.8B | DKK 350.54 | 0.27% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | DKK 32.9B | DKK 188.96 | 0.25% down | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | DKK 33.2B | DKK 397.31 | 3.16% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | DKK 223.6B | DKK 550.34 | 5.59% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | DKK 62.8B | DKK 2,702.58 | 0.34% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | DKK 48.1B | DKK 549.39 | 3.79% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | DKK 57.6B | DKK 72.00 | 0.67% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | DKK 215.9B | DKK 984.06 | 20.58% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | DKK 21.3B | DKK 109.67 | 0.92% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | DKK 30.9B | DKK 185.42 | 0.62% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | DKK 134.9B | DKK 1,006.95 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8120 DKK).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 21:37 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of DKK 33.8T as of 19 Nov 2026, 21:37 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.